Literature DB >> 33758114

Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism.

Alyssa Peterkin1, Corey S Davis, Zoe Weinstein.   

Abstract

Since early 2020 COVID-19 has swept across the United States, exposing shortcomings in the current healthcare delivery system. Although some interim efforts have been made to mitigate the spread of infection and maintain access to treatment for opioid use disorder, more permanent changes are needed to combat the ongoing opioid crisis. In this commentary, we describe the regulatory barriers to methadone maintenance treatment that disproportionately impact communities of color. We then discuss strategies supporting more equitable access to this proven treatment for opioid use disorder.
Copyright © 2021 American Society of Addiction Medicine.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33758114     DOI: 10.1097/ADM.0000000000000841

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  3 in total

1.  COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.

Authors:  Ximena A Levander; Jarratt D Pytell; Kenneth B Stoller; P Todd Korthuis; Geetanjali Chander
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.716

2.  Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.

Authors:  Ximena A Levander; Kim A Hoffman; John W McIlveen; Dennis McCarty; Javier Ponce Terashima; P Todd Korthuis
Journal:  Addict Sci Clin Pract       Date:  2021-12-11

3.  Reply to Letter to the Editor Regarding Article: "Considering the Potential Benefits of Over-The-Counter Naloxone" [Response To Letter].

Authors:  Kirk E Evoy; Lucas G Hill; Corey S Davis
Journal:  Integr Pharm Res Pract       Date:  2021-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.